Biotechnology Acquisitions in Vermont
Showing 1 transactions.
-
October 11, 2019
- Buyer
- Edgewater Capital Partners
- Target
- Haematologic Technologies Incorporated
- Industry
- Biotechnology
- Location
- Vermont, United States
- Type
- Buyout
Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.